Health
Heart Transplant ‘Liquid Biopsy’; PCSK9 CRISPR; More SGLT2 Drugs Try FDA in HF – MedPage Today
Recent developments of interest in cardiovascular medicine
A blood test showed promise as a “liquid biopsy” for detection of acute heart transplant rejection. (Circulation)
Early efforts to use CRISPR to edit PCSK9 genes in severe heterozygous familial hypercholesterolemia are moving forward. (Endpoints News)
In a study of 145 student athletes with no more than moderate COVID-19 symptoms, cardiac MRI a median 15 days after the positive test was consistent with myocarditis in two (1.4%). (JAMA Cardiology)
Each extra serving of fried foods per week was linked…
-
General21 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
General19 hours agoIslam Makhachev claims UFC welterweight belt with dominant win over Jack Della Maddalena
-
Noosa News9 hours agoGovernment auditors suspected lab was conducting shonky tests on infrastructure projects
-
Noosa News22 hours agoState government renews national demand for health funding